Medication adherence and health care utilization in pediatric chronic illness: A systematic review

Pediatrics

Volumn 132, Issue 4, 2013, Pages 730-740

  McGrady, Meghan E ^a   Hommel, Kevin A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Access; And evaluation; Chronic disease; Health care costs; Health care quality; Medication adherence

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ASTHMA; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MORBIDITY; OBSERVATIONAL STUDY; OUTPATIENT; OUTPATIENT CARE; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SCHOOL CHILD; SELF REPORT; SYSTEMATIC REVIEW; UNITED STATES;

CHRONIC DISEASE; HEALTH CARE COSTS; HEALTH CARE QUALITY, ACCESS, AND EVALUATION; MEDICATION ADHERENCE;

ADOLESCENT; CHILD; CHRONIC DISEASE; DELIVERY OF HEALTH CARE; HUMANS; MEDICATION ADHERENCE; PEDIATRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84885111212     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1451     Document Type: Review

References (51)

1. Martin AB, Lassman D, Washington B, Catlin A; National Health Expenditure Accounts Team. Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Aff (Millwood). 2012;31(1):208-219
2. Schoenman J, Chockley N. Understanding U.S. Health Care Spending. Washington, DC: NIHCM Data Brief; 2011:1-13
3. Haber S, McCall N, Cromwell G. Children With High Health Care Utilization and Special Health Care Needs: Draft Manuscript. Washington, DC: RTI International; 2007
4. Emanuel EJ. Where are the health care cost savings? JAMA. 2012;307(1):39-40
5. Partnership for Solutions. Chronic Conditions: Making the Case for Ongoing Care. Baltimore, MD: The Johns Hopkins University; 2002
6. Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. JAMA. 2010;303(7):623-630
7. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics. 2002;109(5). Available at: www.pediatrics.org/cgi/ content/full/109/5/e81
8. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106(3):493-499
9. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2010 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2010
10. Smith JM, Martz K, Blydt-Hansen TD. Pediatric kidney transplant practice patterns and outcome benchmarks, 1987-2010: A report of the North American Pediatric Renal Trials and Collaborative Studies. Pediatr Transplant. 2013;17(2):149-157
11. Berry JG, Hall M, Hall DE, et al. Inpatient growth and resource use in 28 children's hospitals: a longitudinal, multi-institutional study. JAMA Pediatr. 2013;167(2):170-177
12. Chevarley FM. Utilization and Expenditures for Children With Special Health Care Needs. Rockville, MD: Agency for Healthcare Research and Quality; 2006
13. Newacheck PW, Kim SE. A national profile of health care utilization and expenditures for children with special health care needs. Arch Pediatr Adolesc Med. 2005;159(1): 10-17
14. Modi AC, Pai AL, Hommel KA, et al. Pediatric self-management: A framework for research, practice, and policy. Pediatrics. 2012;129(2). Available at: www.pediatrics.org/cgi/content/full/129/2/e473
15. Sabate E. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003
16. Bender BG, Rand C. Medication nonadherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004;4(3): 191-195
17. Muenchberger H, Kendall E. Predictors of preventable hospitalization in chronic disease: priorities for change. J Public Health Policy. 2010;31(2):150-163
18. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91-99
19. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(9 suppl):S1-S24
20. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209
21. Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33(6):590-611
22. Newacheck PW, Taylor WR. Childhood chronic illness: prevalence, severity, and impact. Am J Public Health. 1992;82(3):364-371
23. Rapoff MA. Adherence to Pediatric Medical Regimens. New York, NY: Springer; 2010
24. Logan D, Zelikovsky N, Labay L, Spergel J. The Illness Management Survey: identifying adolescents' perceptions of barriers to adherence. J Pediatr Psychol. 2003;28(6): 383-392
25. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(4):589-593
26. de Brantes F, Rosenthal MB, Painter M. Building a bridge from fragmentation to accountability-the Prometheus Payment model. N Engl J Med. 2009;361(11):1033-1036
27. Federal Interagency Forum on Child and Family Statistics. America's Children in Brief: Key National Indicators of Well-Being, 2012. Washington, DC: U.S. Government Printing Office; 2012
28. Stille C, Turchi RM, Antonelli R, et al; Academic Pediatric Association Task Force on Family-Centered Medical Home. The familycentered medical home: specific considerations for child health research and policy. Acad Pediatr. 2010;10(4):211-217
29. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535
30. Vandenbroucke JP, von Elm E, Altman DG, et al; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297
31. Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008;33(9):916-936, discussion 937-938
32. Wells G, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Paper presented at 3rd Symposium on Systematic Reviews: Beyond the Basics; 2000
33. Higgins JPT, Altman DG. Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions. West Sussex, England: John Wiley & Sons, Ltd; 2008:187-241
34. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107(4):706-711
35. Smith SR, Wakefield DB, Cloutier MM. Relationship between pediatric primary provider visits and acute asthma ED visits. Pediatr Pulmonol. 2007;42(11):1041-1047
36. Herndon JB, Mattke S, Evans Cuellar A, Hong SY, Shenkman EA. Anti-inflammatory medication adherence, healthcare utilization and expenditures among Medicaid and children's health insurance program enrollees with asthma. Pharmacoeconomics. 2012;30(5):397-412
37. Walders N, Kopel SJ, Koinis-Mitchell D, McQuaid EL. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr. 2005;146(2): 177-182
38. Ashkenazi S, Amir J, Volovitz B, Varsano I. Why do asthmatic children need referral to an emergency room? Pediatr Allergy Immunol. 1993;4(2):93-96
39. Zhao J, He Q, Zhang G, et al. Status of asthma control in children and the effect of parents' knowledge, attitude, and practice (KAP) in China: a multicenter study. Ann Allergy Asthma Immunol. 2012;109(3):190-194
40. Bartlett SJ, Krishnan JA, Riekert KA, Butz AM, Malveaux FJ, Rand CS. Maternal depressive symptoms and adherence to therapy in inner-city children with asthma. Pediatrics. 2004;113(2):229-237
41. Bauman LJ, Wright E, Leickly FE, et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics. 2002;110(1 pt 1). Available at: www.pediatrics.org/cgi/content/full/110/1/e6
42. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997;350(9090):1505-1510
43. McNally KA, Rohan J, Schluchter M, et al. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. J Asthma. 2009;46(9):921-927
44. Encinosa WE, Bernard D, Dor A. Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes. Adv Health Econ Health Serv Res. 2010;22: 151-173
45. Valenti WM. Treatment adherence improves outcomes and manages costs. AIDS Read. 2001;11(2):77-80
46. Agency for Healthcare Research and Quality. Total health services-mean and median expenses per person with expense and distribution of expenses by source of payment: United States, 2010. Medical Expenditure Panel Survey Household Component Data. Available at: http://meps.ahrq.gov/mepsweb/. Accessed July 8, 2013
47. Graves MM, Roberts MC, Rapoff M, Boyer A. The efficacy of adherence interventions for chronically ill children: a meta-analytic review. J Pediatr Psychol. 2010;35(4):368-382
48. Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract. 2010;64(2):169-181
49. Chapman RH, Kowal SL, Cherry SB, Ferrufino CP, Roberts CS, Chen L. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. Value Health. 2010;13(6):685-694
50. Desborough JA, Sach T, Bhattacharya D, Holland RC, Wright DJ. A cost-consequences analysis of an adherence focused pharmacistled medication review service. Int J Pharm Pract. 2012;20(1):41-49
51. Patrick AR, Schousboe JT, Losina E, Solomon DH. The economics of improving medication adherence in osteoporosis: validation and application of a simulation model. J Clin Endocrinol Metab. 2011;96(9):2762-2770